169 related articles for article (PubMed ID: 12085205)
1. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.
Naccarato AG; Marcocci C; Miccoli P; Bonadio AG; Cianferotti L; Vignali E; Cipollini G; Viacava P
J Endocrinol Invest; 1998 Mar; 21(3):136-41. PubMed ID: 9591207
[TBL] [Abstract][Full Text] [Related]
3. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
[TBL] [Abstract][Full Text] [Related]
4. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.
Ozer E; Canda MS; Ulukus C; Guray M; Erbayraktar S
Tumori; 2003; 89(1):54-9. PubMed ID: 12729363
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680
[TBL] [Abstract][Full Text] [Related]
7. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
Kikuchi Y; Dinjens WN; Bosman FT
Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
[TBL] [Abstract][Full Text] [Related]
10. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
Borre M; Stausbol-Gron B; Overgaard J
J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
12. p53 and Ki67 in adrenocortical tumors.
Arola J; Salmenkivi K; Liu J; Kahri AI; Heikkilä P
Endocr Res; 2000 Nov; 26(4):861-5. PubMed ID: 11196463
[TBL] [Abstract][Full Text] [Related]
13. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
15. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
[TBL] [Abstract][Full Text] [Related]
16. Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex.
Reincke M; Beuschlein F; Menig G; Hofmockel G; Arlt W; Lehmann R; Karl M; Allolio B
J Endocrinol; 1998 Mar; 156(3):415-23. PubMed ID: 9582497
[TBL] [Abstract][Full Text] [Related]
17. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis.
Nomura M; Watari J; Yokota K; Saitoh Y; Obara T; Kohgo Y
Virchows Arch; 2000 Jul; 437(1):17-24. PubMed ID: 10963375
[TBL] [Abstract][Full Text] [Related]
18. p53 protein and its messenger ribonucleic acid in human adrenal tumors.
Adleff V; Rácz K; Tóth M; Varga I; Bezzegh A; Gláz E
J Endocrinol Invest; 1998 Dec; 21(11):753-7. PubMed ID: 9972675
[TBL] [Abstract][Full Text] [Related]
19. Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules.
Viacava P; Bocci G; Tonacchera M; Fanelli G; DeServi M; Agretti P; Berti E; Goletti O; Aretini P; Resta ML; Bevilacqua G; Naccarato AG
Thyroid; 2007 Mar; 17(3):191-7. PubMed ID: 17381350
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]